Skip to main content
. 2017 Apr 26;16:176. doi: 10.1186/s12936-017-1827-7

Table 1.

Study name, background characteristics, grouping, hematological profiles and time of data collection of samples used within the study

Study identifier (population) Sampling period (month/year) No. of participants Median age in years (range) Mean hemoglobin (g/dL) Vaccine allocation Samples time points
GMZ2_3_08
(Children) [36]
09/2008–10/2009 30 3.5 (1–5) 10.5
10.5
10.3
GMZ2 100 µg
GMZ2 30 µg
Rabies
Days 0 and 84
GMZ2_2_07
(Adults) [37]
07/2007–08/2008 32 26.3 (18–45) 13.8
14.1
GMZ2 100 µg
Rabies
Days 0 and 84